Please wait while the formulary information is being retrieved.
GLEOSTINE (LOMUSTINE)
- Hodgkin's lymphoma
- Neoplasm of brain
10 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
100 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
40 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
5 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
10 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
100 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
40 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
5 mg capsule
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
Hodgkin's lymphoma
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
Neoplasm of brain
- 130 mg/m2 (round dose to nearest 5 mg) by oral route every 6 weeks
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- None
- Lactating mother
Contraindicated
- Bone marrow depression
- Hemorrhage
- Kidney disease with reduction in GFR
- Leukopenia
- Pregnancy
- Pulmonary fibrosis
- Pulmonary infiltrates
- Thrombocytopenic disorder
Severe
Moderate
- Abnormal hepatic function tests
- Hyperbilirubinemia
GLEOSTINE (LOMUSTINE)
- Hodgkin's lymphoma
- Neoplasm of brain
- Bone marrow depression
- Immunosuppression
- Infection
- Leukopenia
- Thrombocytopenic disorder
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Abnormal hepatic function tests
- Anemia
- CNS toxicity
- Kidney disease with reduction in GFR
- Optic atrophy
- Renal failure
- Transient blindness
- Acute confusion
- Alopecia
- Ataxia
- Dysarthria
- Lethargy
- Stomatitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute leukemia
- Drug-induced hepatitis
- Jaundice
- Myelodysplastic syndrome
- Pulmonary fibrosis
- Pulmonary infiltrates
Less Severe
- Visual changes
Contraindicated
None
Severe Precaution
Lomustine
Risk of long term toxicity of pulmonary infiltrates or fibrosis. Limited safety data available,
- 1 Day – 18 Years
- Risk of long term toxicity of pulmonary infiltrates or fibrosis. Limited safety data available,
Management or Monitoring Precaution
None
Lomustine
- Severity Level:
D
- Additional Notes: Insuff human data; based on pharmacology and animal data dev tox may occur
Contraindicated
Lomustine
Serious adv effects possible;Avoid nursing during & for 2 wks after last dose
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Serious adv effects possible;Avoid nursing during & for 2 wks after last dose |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Lomustine decreases bone marrow function, an effect (possibly fatal) that may lead to a low number of blood cells such as red cells, white cells, and platelets. This effect can cause anemia, decrease your body's ability to fight an infection, or cause easy bruising/bleeding. These side effects usually occur 4 to 6 weeks after your dose and may last for 1 to 2 weeks.<br /><br />Tell your doctor right away if you develop any of the following symptoms: unusual tiredness, pale skin, signs of infection (such as sore throat that doesn't go away, fever, chills), easy bruising/bleeding. Your doctor will closely monitor you and perform weekly blood tests for at least 6 weeks after each dose. Your dose and any further treatment will be based on your blood tests.<br /><br />Due to serious side effects, do not take this medication more often than once every 6 weeks. Follow your doctor's instructions carefully.
Hodgkin's lymphoma | |
C81 | Hodgkin lymphoma |
C81.0 | Nodular lymphocyte predominant hodgkin lymphoma |
C81.00 | Nodular lymphocyte predominant hodgkin lymphoma, unspecified site |
C81.01 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.02 | Nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes |
C81.03 | Nodular lymphocyte predominant hodgkin lymphoma, intra-abdominal lymph nodes |
C81.04 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.05 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.06 | Nodular lymphocyte predominant hodgkin lymphoma, intrapelvic lymph nodes |
C81.07 | Nodular lymphocyte predominant hodgkin lymphoma, spleen |
C81.08 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of multiple sites |
C81.09 | Nodular lymphocyte predominant hodgkin lymphoma, extranodal and solid organ sites |
C81.1 | Nodular sclerosis hodgkin lymphoma |
C81.10 | Nodular sclerosis hodgkin lymphoma, unspecified site |
C81.11 | Nodular sclerosis hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.12 | Nodular sclerosis hodgkin lymphoma, intrathoracic lymph nodes |
C81.13 | Nodular sclerosis hodgkin lymphoma, intra-abdominal lymph nodes |
C81.14 | Nodular sclerosis hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.15 | Nodular sclerosis hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.16 | Nodular sclerosis hodgkin lymphoma, intrapelvic lymph nodes |
C81.17 | Nodular sclerosis hodgkin lymphoma, spleen |
C81.18 | Nodular sclerosis hodgkin lymphoma, lymph nodes of multiple sites |
C81.19 | Nodular sclerosis hodgkin lymphoma, extranodal and solid organ sites |
C81.2 | Mixed cellularity hodgkin lymphoma |
C81.20 | Mixed cellularity hodgkin lymphoma, unspecified site |
C81.21 | Mixed cellularity hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.22 | Mixed cellularity hodgkin lymphoma, intrathoracic lymph nodes |
C81.23 | Mixed cellularity hodgkin lymphoma, intra-abdominal lymph nodes |
C81.24 | Mixed cellularity hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.25 | Mixed cellularity hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.26 | Mixed cellularity hodgkin lymphoma, intrapelvic lymph nodes |
C81.27 | Mixed cellularity hodgkin lymphoma, spleen |
C81.28 | Mixed cellularity hodgkin lymphoma, lymph nodes of multiple sites |
C81.29 | Mixed cellularity hodgkin lymphoma, extranodal and solid organ sites |
C81.3 | Lymphocyte depleted hodgkin lymphoma |
C81.30 | Lymphocyte depleted hodgkin lymphoma, unspecified site |
C81.31 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.32 | Lymphocyte depleted hodgkin lymphoma, intrathoracic lymph nodes |
C81.33 | Lymphocyte depleted hodgkin lymphoma, intra-abdominal lymph nodes |
C81.34 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.35 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.36 | Lymphocyte depleted hodgkin lymphoma, intrapelvic lymph nodes |
C81.37 | Lymphocyte depleted hodgkin lymphoma, spleen |
C81.38 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of multiple sites |
C81.39 | Lymphocyte depleted hodgkin lymphoma, extranodal and solid organ sites |
C81.4 | Lymphocyte-rich hodgkin lymphoma |
C81.40 | Lymphocyte-rich hodgkin lymphoma, unspecified site |
C81.41 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.42 | Lymphocyte-rich hodgkin lymphoma, intrathoracic lymph nodes |
C81.43 | Lymphocyte-rich hodgkin lymphoma, intra-abdominal lymph nodes |
C81.44 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.45 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.46 | Lymphocyte-rich hodgkin lymphoma, intrapelvic lymph nodes |
C81.47 | Lymphocyte-rich hodgkin lymphoma, spleen |
C81.48 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of multiple sites |
C81.49 | Lymphocyte-rich hodgkin lymphoma, extranodal and solid organ sites |
C81.7 | Other hodgkin lymphoma |
C81.70 | Other hodgkin lymphoma, unspecified site |
C81.71 | Other hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.72 | Other hodgkin lymphoma, intrathoracic lymph nodes |
C81.73 | Other hodgkin lymphoma, intra-abdominal lymph nodes |
C81.74 | Other hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.75 | Other hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.76 | Other hodgkin lymphoma, intrapelvic lymph nodes |
C81.77 | Other hodgkin lymphoma, spleen |
C81.78 | Other hodgkin lymphoma, lymph nodes of multiple sites |
C81.79 | Other hodgkin lymphoma, extranodal and solid organ sites |
C81.9 | Hodgkin lymphoma, unspecified |
C81.90 | Hodgkin lymphoma, unspecified, unspecified site |
C81.91 | Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
C81.92 | Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
C81.93 | Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
C81.94 | Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
C81.95 | Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
C81.96 | Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
C81.97 | Hodgkin lymphoma, unspecified, spleen |
C81.98 | Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
C81.99 | Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
Neoplasm of brain | |
C71 | Malignant neoplasm of brain |
C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles |
C71.1 | Malignant neoplasm of frontal lobe |
C71.2 | Malignant neoplasm of temporal lobe |
C71.3 | Malignant neoplasm of parietal lobe |
C71.4 | Malignant neoplasm of occipital lobe |
C71.5 | Malignant neoplasm of cerebral ventricle |
C71.6 | Malignant neoplasm of cerebellum |
C71.7 | Malignant neoplasm of brain stem |
C71.8 | Malignant neoplasm of overlapping sites of brain |
C71.9 | Malignant neoplasm of brain, unspecified |
C79.31 | Secondary malignant neoplasm of brain |
D43 | Neoplasm of uncertain behavior of brain and central nervous system |
D43.0 | Neoplasm of uncertain behavior of brain, supratentorial |
D43.1 | Neoplasm of uncertain behavior of brain, infratentorial |
D43.2 | Neoplasm of uncertain behavior of brain, unspecified |
D49.6 | Neoplasm of unspecified behavior of brain |
0-9 | A-Z |
---|---|
C71 | Malignant neoplasm of brain |
C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles |
C71.1 | Malignant neoplasm of frontal lobe |
C71.2 | Malignant neoplasm of temporal lobe |
C71.3 | Malignant neoplasm of parietal lobe |
C71.4 | Malignant neoplasm of occipital lobe |
C71.5 | Malignant neoplasm of cerebral ventricle |
C71.6 | Malignant neoplasm of cerebellum |
C71.7 | Malignant neoplasm of brain stem |
C71.8 | Malignant neoplasm of overlapping sites of brain |
C71.9 | Malignant neoplasm of brain, unspecified |
C79.31 | Secondary malignant neoplasm of brain |
C81 | Hodgkin lymphoma |
C81.0 | Nodular lymphocyte predominant hodgkin lymphoma |
C81.00 | Nodular lymphocyte predominant hodgkin lymphoma, unspecified site |
C81.01 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.02 | Nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes |
C81.03 | Nodular lymphocyte predominant hodgkin lymphoma, intra-abdominal lymph nodes |
C81.04 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.05 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.06 | Nodular lymphocyte predominant hodgkin lymphoma, intrapelvic lymph nodes |
C81.07 | Nodular lymphocyte predominant hodgkin lymphoma, spleen |
C81.08 | Nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of multiple sites |
C81.09 | Nodular lymphocyte predominant hodgkin lymphoma, extranodal and solid organ sites |
C81.1 | Nodular sclerosis hodgkin lymphoma |
C81.10 | Nodular sclerosis hodgkin lymphoma, unspecified site |
C81.11 | Nodular sclerosis hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.12 | Nodular sclerosis hodgkin lymphoma, intrathoracic lymph nodes |
C81.13 | Nodular sclerosis hodgkin lymphoma, intra-abdominal lymph nodes |
C81.14 | Nodular sclerosis hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.15 | Nodular sclerosis hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.16 | Nodular sclerosis hodgkin lymphoma, intrapelvic lymph nodes |
C81.17 | Nodular sclerosis hodgkin lymphoma, spleen |
C81.18 | Nodular sclerosis hodgkin lymphoma, lymph nodes of multiple sites |
C81.19 | Nodular sclerosis hodgkin lymphoma, extranodal and solid organ sites |
C81.2 | Mixed cellularity hodgkin lymphoma |
C81.20 | Mixed cellularity hodgkin lymphoma, unspecified site |
C81.21 | Mixed cellularity hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.22 | Mixed cellularity hodgkin lymphoma, intrathoracic lymph nodes |
C81.23 | Mixed cellularity hodgkin lymphoma, intra-abdominal lymph nodes |
C81.24 | Mixed cellularity hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.25 | Mixed cellularity hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.26 | Mixed cellularity hodgkin lymphoma, intrapelvic lymph nodes |
C81.27 | Mixed cellularity hodgkin lymphoma, spleen |
C81.28 | Mixed cellularity hodgkin lymphoma, lymph nodes of multiple sites |
C81.29 | Mixed cellularity hodgkin lymphoma, extranodal and solid organ sites |
C81.3 | Lymphocyte depleted hodgkin lymphoma |
C81.30 | Lymphocyte depleted hodgkin lymphoma, unspecified site |
C81.31 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.32 | Lymphocyte depleted hodgkin lymphoma, intrathoracic lymph nodes |
C81.33 | Lymphocyte depleted hodgkin lymphoma, intra-abdominal lymph nodes |
C81.34 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.35 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.36 | Lymphocyte depleted hodgkin lymphoma, intrapelvic lymph nodes |
C81.37 | Lymphocyte depleted hodgkin lymphoma, spleen |
C81.38 | Lymphocyte depleted hodgkin lymphoma, lymph nodes of multiple sites |
C81.39 | Lymphocyte depleted hodgkin lymphoma, extranodal and solid organ sites |
C81.4 | Lymphocyte-rich hodgkin lymphoma |
C81.40 | Lymphocyte-rich hodgkin lymphoma, unspecified site |
C81.41 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.42 | Lymphocyte-rich hodgkin lymphoma, intrathoracic lymph nodes |
C81.43 | Lymphocyte-rich hodgkin lymphoma, intra-abdominal lymph nodes |
C81.44 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.45 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.46 | Lymphocyte-rich hodgkin lymphoma, intrapelvic lymph nodes |
C81.47 | Lymphocyte-rich hodgkin lymphoma, spleen |
C81.48 | Lymphocyte-rich hodgkin lymphoma, lymph nodes of multiple sites |
C81.49 | Lymphocyte-rich hodgkin lymphoma, extranodal and solid organ sites |
C81.7 | Other hodgkin lymphoma |
C81.70 | Other hodgkin lymphoma, unspecified site |
C81.71 | Other hodgkin lymphoma, lymph nodes of head, face, and neck |
C81.72 | Other hodgkin lymphoma, intrathoracic lymph nodes |
C81.73 | Other hodgkin lymphoma, intra-abdominal lymph nodes |
C81.74 | Other hodgkin lymphoma, lymph nodes of axilla and upper limb |
C81.75 | Other hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
C81.76 | Other hodgkin lymphoma, intrapelvic lymph nodes |
C81.77 | Other hodgkin lymphoma, spleen |
C81.78 | Other hodgkin lymphoma, lymph nodes of multiple sites |
C81.79 | Other hodgkin lymphoma, extranodal and solid organ sites |
C81.9 | Hodgkin lymphoma, unspecified |
C81.90 | Hodgkin lymphoma, unspecified, unspecified site |
C81.91 | Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
C81.92 | Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
C81.93 | Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
C81.94 | Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
C81.95 | Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
C81.96 | Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
C81.97 | Hodgkin lymphoma, unspecified, spleen |
C81.98 | Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
C81.99 | Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
D43 | Neoplasm of uncertain behavior of brain and central nervous system |
D43.0 | Neoplasm of uncertain behavior of brain, supratentorial |
D43.1 | Neoplasm of uncertain behavior of brain, infratentorial |
D43.2 | Neoplasm of uncertain behavior of brain, unspecified |
D49.6 | Neoplasm of unspecified behavior of brain |
Formulary Reference Tool